default author photo

Xiaowei Meng

China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy

Nanjing

China

SCHOLARLY PAPERS

1

DOWNLOADS

152

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Tumour Microenvironment-Based Molecular Profiling Reveals Ideal Candidates for High-Grade Serous Ovarian Cancer Immunotherapy

Number of pages: 52 Posted: 19 Nov 2019
Xiaofan Lu, Caoyu Ji, Liyun Jiang, Yang Wang, Yue Zhu, Jun Gao, Yu Cheng, Xinjia Ruan, Jiashuo Wang, Zhengbao Xu, Xiaowei Meng, Wenjun Hu, Bing Zhang, Tao Lu, Junmei Ye and Fang-Rong Yan
China Pharmaceutical University - State Key Laboratory of Natural Medicines, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, Nanjing University - Department of Radiology, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University - Research Center of Biostatistics and Computational Pharmacy, Nanjing University - Department of Radiology, China Pharmaceutical University - State Key Laboratory of Natural Medicines, China Pharmaceutical University - State Key Laboratory of Natural Medicines and China Pharmaceutical University - State Key Laboratory of Natural Medicines
Downloads 152 (488,442)

Abstract:

Loading...

high-grade serous ovarian cancer, molecular classification, immune-specific subtype, 59 tumour microenvironment, immunotherapy response